European Journal of Health Economics

Article	Citations
Education and medication use later in life and the role of intelligence	72
Beyond 10-year lead-times in EQ-5D-5L: leveraging alternative lead-times in willingness-to-accept questions to capture preferences for worse-than-dead states and their implication	67
Costing methodologies in European economic evaluation guidelines: commonalities and divergences	59
Should Scotland provide genome-wide sequencing for the diagnosis of rare developmental disorders? A cost-effectiveness analysis	55
Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC4E trial in 15 European countries	55
Correction to: Geographic distribution of physicians in Portugal	44
Characteristics and health care costs in patients with a diagnostic imaging for low back pain in Switzerland	40
Psychometric properties and general population reference values for PROMIS Global Health in Hungary	39
Pragmatic randomized controlled trial comparing a complex telemedicine-based intervention with usual care in patients with chronic conditions	34
Comparing the measurement properties of the EQ-5D-Y-3L, EQ-5D-Y-5L and CHU9D in children and adolescents: a measurement property study	32
The hidden cost of sophistication: economic complexity and obesity	31
Patient-level cost analysis of subfertility pathways in the Dutch healthcare system	28
Cost-effectiveness and budget impact of venetoclax in combination with rituximab in relapsed/refractory chronic lymphocytic leukemia in Switzerland	28
Cost-effectiveness of transcatheter aortic valve implantation in patients at low surgical risk in France: a model-based analysis of the Evolut LR trial	28
Prescription opioids and economic hardship in France	26
Comparative cost-effectiveness of nivolumab first-line and second-line therapy for advanced esophageal cancer in Japan	25
Cost awareness among intensivists in their daily clinical practice: a prospective multicentre study	24
Cost-effectiveness analysis of vaborem for the treatment of carbapenem-resistant Enterobacteriaceae-Klebsiella pneumoniae carbapenemase (CRE-KPC) infections in the UK	23
The employment situation of people living with HIV: a closer look at the effects of the 2008 economic crisis	23
Workload and short sickness absences in a cohort of Finnish hospital employees	23
From test to rest: evaluating socioeconomic differences along the COVID-19 care pathway in the Netherlands	22
Expensive today but cheaper tomorrow: lifetime costs of an active middle ear implant compared to alternative treatment options	22
Setting incentives right with long-term risk adjustment	21
Primary care services and emergency department visits in blended fee-for-service and blended capitation models: evidence from Ontario, Canada	21
Nothing about us, without us? A reflection on and call for involving children in the process of valuing child health	21

Economic assessment of abemaciclib for the adjuvant treatment of luminal HER2- breast cancer from the perspective of the Spanish health system	19
Cost-effectiveness of encorafenib with binimetinib in unresectable or metastatic BRAF-mutant melanoma	19
Health-related quality of life in patients with alcohol use disorder: comparing instruments and mapping from clinical measures to preference-based measures	19
On spillovers in economic evaluations: definition, mapping review and research agenda	18
Trends in NICE technology appraisals of non-small cell lung cancer drugs over the last decade	18
The EORTC QLU-C10D is a valid cancer-specific preference-based measure for cost-utility and health technology assessment in the Netherlands	18
The costs of celiac disease: a contingent valuation in Switzerland	18
The causal effect of catastrophic health expenditure on poverty in Poland	18
Correction: AOTMiT reimbursement recommendations compared to other HTA agencies	17
Breaking the rules: decision-making under absolute resource constraints	17
Antivirals to prepare for surges in influenza cases: an economic evaluation of baloxavir marboxil for the Netherlands	17
Hospital resource utilisation from HPV-related diseases in England: a real-world cost analysis	17
Generating EQ-5D-5L health utility scores from BASDAI and BASFI: a mapping study in patients with axial spondyloarthritis using longitudinal UK registry data	17
How perceptions of bone marrow donation costs affect donation behavior: survey evidence from a large donor registry	16
Analyzing nurses’ decisions to leave their profession—a duration analysis	16
The trade-off between health system resiliency and efficiency: evidence from COVID-19 in European regions	16
Benefits beyond health in the willingness to pay for a quality-adjusted life-year	16
Can competition improve hospital quality of care? A difference-in-differences approach to evaluate the effect of increasing quality transparency on hospital quality	16
Measuring health-related quality of life and well-being: a head-to-head psychometric comparison of the EQ-5D-5L, ReQoL-UI and ICECAP-A	15
The social value of gambling: surplus estimates by gambling types for France	15
The impacts of working from home on individual health and well-being	15
A principled approach to non-discrimination in cost-effectiveness	15
Estimating loss in capability wellbeing in the first year of the COVID-19 pandemic: a cross-sectional study of the general adult population in the UK, Australia and the Netherlands	15
Costs attributable to hypercholesterolemia in a single period and over the life cycle	15
The impact on quality of life of diet restrictions and disease symptoms associated with phenylketonuria: a time trade-off and discrete choice experiment study	14
The goal of risk equalization in regulated competitive health insurance markets	14
Is ultra-hypo-fractionated radiotherapy more cost-effective relative to conventional fractionation in treatment of prostate cancer? A cost–utility analysis alongside a randomized HYPO-RT-PC trial	14
Economic value of diastasis repair with the use of mesh compared to no intervention in Italy	14
Time value of informal care of people with alzheimer’s disease in Spain: a population-based analysis	14
Sex differences in care complexity and cost of cardiac-related procedures as a basis for improving hospital payments systems	14
Adverse selection and consumer inertia: empirical evidence from the Dutch health insurance market	13
Does prescribing apixaban or rivaroxaban versus warfarin for patients diagnosed with atrial fibrillation save health system costs? A multivalued treatment effects analysis	13
The impact of ambulatory care spending, continuity and processes of care on ambulatory care sensitive hospitalizations	13
Machine learning versus regression modelling in predicting individual healthcare costs from a representative sample of the nationwide claims database in France	13
Modeling European health systems: an ideal chain of services	12
The attractiveness of jobs in the German care sector: results of a factorial survey	12
Pharmacy cost groups for the German morbidity-based risk compensation scheme	12
A comprehensive review of official discount rates in guidelines of health economic evaluations over time: the trends and roots	12
Work ethics, stay-at-home measures and COVID-19 diffusion	12
Does medial tourism promote growth in healthcare sector?	12
Valuation of the EQ-5D-3L in Jordan	12
Do mobile hospital teams in residential aged care facilities increase health care efficiency: an evaluation of French residential care policy	12
Validation of the PAM-13 instrument in the Hungarian general population 40 years old and above	11
Alcohol prices, the April effect, and the environment, in violence-related injury in England and Wales	11
Preferences for COVID-19 epidemic control measures among French adults: a discrete choice experiment	11
Tenders for generics and biosimilars: a challenging purchasing policy	11
Infections, accidents and nursing overtime in a neonatal intensive care unit	11
Changes in spending, quality indicators, and provider experiences following the introduction of a population-based payment model in dutch primary care: a mixed methods evaluation	11
Scales and size-quality outcomes in adult learning disability residential care: evidence from the UK	11
Do we care about high-cost patients? Estimating the savings on health spending by integrated care	11

Significant healthcare burden and life cost of spinal muscular atrophy: real-world data	10
The effect of mental and physical health problems on sickness absence	10
Modeling the potential efficiency of a blood biomarker-based tool to guide pre-hospital thrombolytic therapy in stroke patients	10
Determinants of willingness to pay for health services: a systematic review of contingent valuation studies	10
Survival analysis of cancer patients in Portugal following the reference centre model implementation	9
Assessment of health state utilities associated with adult and pediatric acid sphingomyelinase deficiency (ASMD)	9
Supply-side solutions targeting demand-side characteristics: causal effects of a chronic disease management program on adherence and health outcomes	9
Optimising the impact of COVID-19 vaccination on mortality and hospitalisations using an individual additive risk measuring approach based on a risk adjustment scheme	9
The ACA Medicaid expansions and abortion rates among young adults	9
Cost-effectiveness of two online interventions supporting self-care for eczema for parents/carers and young people	9
Self-interest, positional concerns and distributional considerations in healthcare preferences	9
Does diagnostic testing always decrease antibiotics prescriptions?	8
Cost-utility of cochlear implantation in single-sided deafness and asymmetric hearing loss: results of a randomized controlled trial	8
Challenges for health systems seeking to embrace virtual health care for population health	8
Recovery of suspended reimbursements of high-cost drugs subjected to monitoring registries and negotiated agreements (MEAs): a tool for governance and clinical appropriateness in the Italian reality	8
Personnel shortages and the provision of long-term care: an empirical analysis of German nursing homes	8
Economics of hypothalamic obesity in patients with craniopharyngioma and other rare sellar/suprasellar tumors	8
Obtaining preference scores for an abbreviated self-completion version of the Teen-Addiction Severity Index (ASC T-ASI) to value therapy outcomes of systemic family interventions: a discrete choice ex	8
The link between physician motivation and care	8
Self vs. other, child vs. adult. An experimental comparison of valuation perspectives for valuation of EQ-5D-Y-3L health states	8
Referring physicians' intention to use hospital report cards for hospital referral purposes in the presence or absence of patient-reported outcomes: a randomized trial	8
Economic evaluation on dental caries preventive interventions for Australian children using a priority-setting approach	8
Healthcare costs of diabetic foot disease in Italy: estimates for event and state costs	8
The pass-through of excise taxes to market prices of heated tobacco products (HTPs) and cigarettes: a cross-country analysis	8
How are patient inputs considered in HTA? A thematic document analysis of NICE ultra-rare disease appraisals	8
Trends and drivers of pharmaceutical expenditures from systemic anti-cancer therapy	7
Psychometric performance of proxy-reported EQ-5D youth version 5-level (EQ-5D-Y-5L) in comparison with three-level (EQ-5D-Y-3L) in children and adolescents with scoliosis	7
Disclosing the ‘Big C’: what does cancer survivorship signal to employers?	7
Seeking efficiency gains outside drugs and diagnostics	7
Generating EQ-5D-3L health utility scores from the Edinburgh Postnatal Depression Scale: a perinatal mapping study	7
The health and long-term care costs in the last year of life in The Netherlands	7
Inpatient care utilisation and expenditure associated with objective physical activity: econometric analysis of the UK Biobank	7
Estimating the additional costs of living with a disability in the United Kingdom between 2013 and 2016	7
Examining the density in out-of-pocket spending share in the estimation of catastrophic health expenditures	7
Impact of the introduction of the AMNOG law on launch delays of new drugs in Germany: a comment	7
Modeling European health systems: a theoretical exercise	7
Assessing Taiwan’s pay-for-performance program for diabetes care: a cost–benefit net value approach	7
Unravelling heterogeneity in efficiency measurements: a case study of public hospitals in Spain	7
Cost-effectiveness evidence on approved cancer drugs in Ireland: the limits of data availability and implications for public accountability	7
Does health technology assessment compromise access to pharmaceuticals?	7
Long-term costs associated with healthcare use of people with cancer in Scotland	6
A hearing bolt-on item increased the measurement properties of the EQ-5D-5L in a community-based hearing loss screening program	6
Health state utilities associated with X-linked retinitis pigmentosa (XLRP)	6
Special FDA designations for drug development: orphan, fast track, accelerated approval, priority review, and breakthrough therapy	6
Correction: Lifetime direct healthcare costs of treating colorectal cancer: a systematic review	6
Cost-effectiveness of the MitraClip device in German heart failure patients with secondary mitral regurgitation	6
One week versus three to five weeks of plaster cast immobilization for nonreduced distal radius fractures, a cost effectiveness analysis embedded in a stepped wedge cluster randomized controlled trial	6
Comparing EQ-5D-5L, PROPr, SF-6D and TTO utilities in patients with chronic skin diseases	6
A critical review of the use of R2 in risk equalization research	6
The performance of the EQ-HWB-S as a measure of quality-of-life of caregivers in families that have experienced adverse events	6
The societal cost of ‘unwanted’ loneliness in Spain	6
Retirement, social support and mental well-being: a couple-level analysis	6
Cost–utility analysis of risk-reducing strategies to prevent breast and ovarian cancer in BRCA-mutation carriers in Switzerland	6
The effect of displaying laboratory test prices on physicians’ ordering behaviour: a systematic review of European studies	6
Obesity and metabolic state are associated with increased healthcare resource and medication use and costs: a Finnish population-based study	6
Time preferences and COVID-19 vaccination uptake	6
Modelling decay in effectiveness for evaluation of behaviour change interventions: a tutorial for public health economists	6
On absolute socioeconomic health inequality comparisons	5
Cost-effectiveness and cost-utility analysis of a nurse-led, transitional care model to improve care coordination for patients with cardiovascular diseases: results from the “Cardiolotse” study	5
Were we happy and we didn’t know it? A subjective dynamic and financial assessment pre-, during and post-COVID-19	5
Does a free maternity policy in Kenya work? Impact and cost–benefit consideration based on demographic health survey data	5
A systematic review of the cost-effectiveness of interventions to increase cervical cancer screening among underserved women in Europe	5
Validity and responsiveness of EQ-5D-Y in children with haematological malignancies and their caregivers	5
The economic burden of obesity in Italy: a cost-of-illness study	5
Valuation of EQ-5D-5L health states from cancer patients’ perspective: a feasibility study	5
A cost-of-illness study of Behçet syndrome in Italy	5
Critical issues with methods and results interpretation at validating the EQ-5D-5L and QLU-C10D utilities in gastric cancer patients	5
Making the rules make sense: valuation of constrained resources	5
Comparison of four approaches in eliciting health state utilities with SF-6Dv2	5
Does the inclusion of societal costs change the economic evaluations recommendations? A systematic review for multiple sclerosis disease	5
Cost-effectiveness analysis of the covered endovascular reconstruction of the aortic bifurcation versus kissing stents and open surgical repair for the treatment of aorto-iliac occlusive disease	5
New evidence on supplier-induced demand in China’s public tertiary hospitals: is the cost of hospitalization higher in the off-season?	5
Risk, time preferences, trustworthiness and COVID-19 preventive behavior: evidence from France	5
Measuring the acceptability of EQ-5D-3L health states for different ages: a new adaptive survey methodology	5
The effect of telephone health coaching and remote exercise monitoring for peripheral artery disease (TeGeCoach) on health care cost and utilization: results of a randomized controlled trial	5
EQ-5D-5L Portuguese population norms	5
Willingness to pay for a quality-adjusted life year: a systematic review with meta-regression	5
Assessing the relation between financial performance and long-term bank loan interest rates for healthcare providers in the Netherlands: a panel data analysis	4
The residential healthcare for the elderly in Italy: some considerations for post-COVID-19 policies	4
Loss aversion in EQ-5D-Y-3L: does it explain differences in willingness to trade-off life years in adults and children?	4

Migration-related determinants of health-care service utilization among persons with a direct migration background in Germany: an exploratory study based on the German Socio-Economic Panel (SOEP)	4
A novel mathematical model for prioritization of individuals to receive vaccine considering governmental health protocols	4
Public versus private healthcare systems in the OECD area– a broad evaluation of performance	4
The handling of missing data in trial-based economic evaluations: should data be multiply imputed prior to longitudinal linear mixed-model analyses?	4
Comparison of the EQ-5D-Y and the CHU-9D instruments in a general child population based on self-reports and proxy-reports	4
The economic burden of asthma in Italy: evaluating the potential impact of different treatments in adult patients with severe eosinophilic asthma	4
Routine measurement in low back pain; towards a pragmatic patient-reported productivity cost outcome measurement using the institute for medical technology assessment productivity cost questionnaire	4
The remarkably frequent use of EQ-5D in non-economic research	4
Resource utilization and disaggregated cost analysis of bariatric surgery in the Australian public healthcare system	4
The impact of inpatient bed capacity on length of stay	4
Shaping a suitable EU HTA dossier template: why the German template is not fit for purpose	4
Complexities of health and acceptance of electronic health records for the Austrian elderly population	4
Financial risk allocation and provider incentives in hospital–insurer contracts in The Netherlands	4
Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L descriptive systems and utilities in atopic dermatitis	4
Early start of anti-dementia medication is associated with lower health and social care costs in Alzheimer´s patients: a Finnish nationwide register study	4
Population normative data for OxCAP-MH capability scores	4
Estimating surgery, radiotherapy and systemic anti-cancer therapy treatment costs for cancer patients by stage at diagnosis	4
Informal care at old age at home and in nursing homes: determinants and economic value	4
Health technology assessment criteria as drivers of coverage with managed entry agreements: a case study of cancer medicines in four countries	4
Cost-effectiveness of 12 months of capecitabine as adjuvant chemotherapy for stage III colon cancer: preplanned cost-effectiveness analysis of the JFMC37-0801 study	4
Out-of-pocket costs sustained in the last 12 months by cancer patients: an Italian survey-based study on individual expenses between 2017 and 2018	4
Comparison of EQ-5D-5L and EORTC QLU-C10D utilities in gastric cancer patients	4
A state-level analysis of macro-level factors associated with hospital readmissions	4
Future medical and non-medical costs and their impact on the cost-effectiveness of life-prolonging interventions: a comparison of five European countries	4
The impact of parastomal hernia on quality of life using data from the CIPHER prospective cohort study	4
Decision thresholds with genetic testing	4
Does the abolition of copayment increase ambulatory care utilization?: a quasi-experimental study in Germany	3
Is there a link between health care utilisation and subjective well-being? An exploratory study among older Danes	3
The common interests of health protection and the economy: evidence from scenario calculations of COVID-19 containment policies	3
Value drivers of development stage biopharma companies	3
Does compulsory schooling affect health? Evidence from ambulatory claims data	3
Costs associated with insufficient physical activity in Germany: cross-sectional results from the baseline examination of the German national cohort (NAKO)	3
Are costs derived from diagnosis-related groups suitable for use in economic evaluations? A comparison across nine European countries in the European Healthcare and Social Cost Database	3
Out-of-pocket expenses of patients with inflammatory bowel disease: a comparison of patient-reported outcomes across 12 European countries	3
Apixaban versus other anticoagulants in patients with nonvalvular fibrillation: a comparison of all-cause and event-related costs in real-life setting in France	3
The EORTC QLU-C10D: the Hong Kong valuation study	3
Test-retest reliability of the Online Elicitation of Personal Utility Functions (OPUF) approach for valuing the EQ-HWB-S	3
Simulating lifestyle and medical interventions to prevent type-2 diabetes: an economic evaluation for Belgium	3
Ageing and health care expenditures: the importance of age per se, steepening of the individual-level expenditure curve, and the role of morbidity	3
Short- and intermediate-term impact of DTC telemedicine consultations on subsequent healthcare consumption	3
Cost-effectiveness of Mavacamten for the treatment of patients with symptomatic obstructive hypertrophic cardiomyopathy using a French healthcare perspective	3
Cost-effectiveness analysis of procalcitonin and lung ultrasonography guided antibiotic prescriptions in primary care	3
Using Australian panel data to account for unobserved factors in measuring inequities for different channels of healthcare utilization	3
Impact of Long COVID on productivity and informal caregiving	3
“COVID-19 and income inequality in OECD countries:” A methodological comment	3
Nexus among health expenditures, ICTs and sustainable economic growth: Insights from South Asian Nationals health and economic issues	3
Estimating the willingness-to-pay to avoid the consequences of foodborne illnesses: a discrete choice experiment	3
Vaccination or NPI? A conjoint analysis of German citizens' preferences in the context of the COVID-19 pandemic	3
Probabilistic microsimulation to examine the cost-effectiveness of hospital admission screening strategies for carbapenemase-producing enterobacteriaceae (CPE) in the United Kingdom	3
Economic evaluation of a complex intervention (Engager) for prisoners with common mental health problems, near to and after release: a cost-utility and cost-consequences analysis	3
What remains after the money ends? Evidence on whether admission reductions continued following the largest health and social care integration programme in England	3
Health shocks and health behavior: a long-term perspective	3
The EQ-5D-3L valuation study for Bermuda: using an on-line EQ-VT protocol	3
Exploring non-iterative time trade-off methods for valuation of EQ-5D-5L health states	3
Is stronger religious faith associated with a greater willingness to take the COVID-19 vaccine? Evidence from Israel and Japan	3
Cancer-specific utility: clinical validation of the EORTC QLU-C10D in patients with glioblastoma	3
Cost-effectiveness analysis alongside the inter-B-NHL ritux 2010 trial: rituximab in children and adolescents with B cell non-Hodgkin’s lymphoma	3
Economic and human burden attributable to antimicrobial resistance in Spain: a holistic macro-estimation of costs	3
Comparing the measurement properties of the EQ-5D-5 L, SF-6Dv2, QLU-C10D and FACT-8D among survivors of classical Hodgkin’s lymphoma	3
Lifetime direct healthcare costs of treating colorectal cancer: a systematic review	3
Country-level effects of diagnosis-related groups: evidence from Germany’s comprehensive reform of hospital payments	2
The formal care costs of dementia: a longitudinal study using Swedish register data	2
Completing the time trade-off with respondents who are older, in poorer health or with an immigrant background in an EQ-5D-5L valuation study	2
Nonprofit behavior altered by monetary donations: evidence from the U.S. hospice industry	2
Population norms for the EQ-5D-5L for Hungary: comparison of online surveys and computer assisted personal interviews	2
Length of hospital stays and financial incentives: evidence from Dutch rehabilitation centers	2
Mapping functions for the PHQ-9 and GAD-7 to generate EQ-5D-3L for economic evaluation	2
Value appropriation in hepatitis C	2
A dynamic Markov model to assess the cost-effectiveness of the Kidney Team at Home intervention in The Netherlands	2
Using machine learning to estimate health spillover effects	2
Does the amount of formal care affect informal care? Evidence among over-60s in France	2
A model-based cost-effectiveness analysis of prescribing by dietitians and therapeutic radiographers in England	2
A Spanish value set for the SF-6D based on the SF-12 v1	2
Does uptake of specialty care affect HRQoL development in COPD patients beneficially? A difference-in-difference analysis linking claims and survey data	2
Dividend policy issues in the European pharmaceutical industry: new empirical evidence	2
Population preferences for non-pharmaceutical interventions to control the SARS-CoV-2 pandemic: trade-offs among public health, individual rights, and economics	2
Changes in disposable income of Polish households and growing trends in alcohol mortality	2
The cost-effectiveness of unilateral cochlear implants in UK adults	2
Catastrophic household expenditure associated with out-of-pocket payments for dental healthcare in Spain	2
Cost-effectiveness of the MitraClip device in secondary mitral regurgitation: comment upon the article by Estler et al.	2
Cost effectiveness of a GP delivered medication review to reduce polypharmacy and potentially inappropriate prescribing in older patients with multimorbidity in Irish primary care: the SPPiRE cluster	2
Monetary value of health—a practical decision-making framework combining equity considerations and WTP	2
How a nation’s well-being influences its health profile: an analysis of critical indicators	2
To what extent does the use of crosswalks instead of EQ-5D value sets impact reimbursement decisions?: a simulation study	2
Time and lexicographic preferences in the valuation of EQ-5D-Y with time trade-off methodology	2
Willingness to pay for health gains from an international integrated early warning system for infectious disease outbreaks	2
How do family doctors respond to reduced waiting times for cancer diagnosis in secondary care?	2
Age, morbidity, and time to death: End-of-life expenditures on health care for the young-old population	2
Healthcare information management and operational cost performance: empirical evidence	2
Burden of myelodysplastic syndromes: a systematic literature review of economic burden	2
Does timing matter? The role of health information shocks in measuring willingness to pay	2
Does competition improve hospital performance: a DEA based evaluation from the Netherlands	2
The causal effect of early retirement on medication use across sex and occupation: evidence from Danish administrative data	2
The added value of the cognition, dining, gastrointestinal problems, sleep and tiredness bolt-on dimensions to the EQ-5D-5L in patients with coeliac disease	2
Incentivizing adherence to pre-exposure prophylaxis for HIV prevention: a randomized pilot trial among male sex workers in Mexico	2